limma powers differential expression analyses for RNA-sequencing and microarray studies is a research paper published in Nucleic Acids Research (2015). On theSindex it has a DataRank of 1.6. It has been cited 42,254 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
1.6
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Health and Medical Research Council (NHMRC)
Grant: 1054618
Computational and statistical bioinformatics for medical “omics”
National Health and Medical Research Council (NHMRC)
Grant: 1050661
Statistical methods for next-generation genomics
National Health and Medical Research Council (NHMRC)
Grant: 1023454
Computational and statistical methods for the analysis of RNA-Seq data
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 4 of ESCO2’s oncogenic role in human tumors: a pan-cancer analysis and experimental validation
Additional file 4 of ESCO2’s oncogenic role in human tumors: a pan-cancer analysis and experimental validation
Additional file 7 of Mapping three-dimensional intratumor proteomic heterogeneity in uterine serous carcinoma by multiregion microsampling
Additional file 7 of Mapping three-dimensional intratumor proteomic heterogeneity in uterine serous carcinoma by multiregion microsampling
Additional file 6 of Mapping three-dimensional intratumor proteomic heterogeneity in uterine serous carcinoma by multiregion microsampling
Additional file 6 of Mapping three-dimensional intratumor proteomic heterogeneity in uterine serous carcinoma by multiregion microsampling
Additional file 5 of Mapping three-dimensional intratumor proteomic heterogeneity in uterine serous carcinoma by multiregion microsampling
Additional file 5 of Mapping three-dimensional intratumor proteomic heterogeneity in uterine serous carcinoma by multiregion microsampling
Additional file 4 of Mapping three-dimensional intratumor proteomic heterogeneity in uterine serous carcinoma by multiregion microsampling
Additional file 4 of Mapping three-dimensional intratumor proteomic heterogeneity in uterine serous carcinoma by multiregion microsampling
Additional file 3 of Mapping three-dimensional intratumor proteomic heterogeneity in uterine serous carcinoma by multiregion microsampling
Additional file 3 of Mapping three-dimensional intratumor proteomic heterogeneity in uterine serous carcinoma by multiregion microsampling
Additional file 2 of Mapping three-dimensional intratumor proteomic heterogeneity in uterine serous carcinoma by multiregion microsampling
Additional file 2 of Mapping three-dimensional intratumor proteomic heterogeneity in uterine serous carcinoma by multiregion microsampling
Additional file 1 of Mapping three-dimensional intratumor proteomic heterogeneity in uterine serous carcinoma by multiregion microsampling
Additional file 1 of Mapping three-dimensional intratumor proteomic heterogeneity in uterine serous carcinoma by multiregion microsampling
Additional file 4 of Genome-wide neonatal epigenetic changes associated with maternal exposure to the COVID-19 pandemic
Additional file 4 of Genome-wide neonatal epigenetic changes associated with maternal exposure to the COVID-19 pandemic
Additional file 3 of Genome-wide neonatal epigenetic changes associated with maternal exposure to the COVID-19 pandemic
Additional file 3 of Genome-wide neonatal epigenetic changes associated with maternal exposure to the COVID-19 pandemic